"EMA will now review all available data to assess whether this emerging information has an impact on the balance of benefits ...

CHMP is reviewing avacopan, a drug authorized in the EU for treating adults with severe, active granulomatosis with polyangiitis or microscopic polyangiitis.

Local county Emergency Management Agencies need your help if you have suffered property damage as a result of the winter ...

Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics ...